. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Preparation of Nanogold-VEGF Antibody Bioconjugates for Potential Anti-Angiogenic Therapy

Reference #:

2004-305

Inventors/Contributors

Priyabrata Mukherjee Ph.D., Debabrata Mukhopadhyay Ph.D., Resham Bhattacharya Ph.D.

Description

In this invention we have prepared a number of nanobioconjugates comprising of gold nanoparticles and VEGF antibody for their potential use in cancer therapeutics. This form of delivery may increase the efficiency, may reduce the toxicity and increase the half life time of VEGF-antibody, and serve as a platform for other therapies as well.

Patent Status

Pending

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410